Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georges A Leconte

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Protocols|December 5, 2022
Targeted Protein Degradation: Design Considerations for PROTAC DevelopmentNathan L Tran, Georges A Leconte, Fleur M Ferguson
Bioorganic & Medicinal Chemistry Letters|August 28, 2025
Biochemical investigations into the incorporation of 8-oxo-2'-deoxyguanosine-5'-triphosphate with two A-family polymerasesMichelle L Hamm, Katherine Alexander, Mary W N Burns, et al.
Journal of Medicinal Chemistry|August 5, 2025
A Lipid Prodrug Strategy Enhances Targeted Protein Degrader CNS PharmacokineticsGeorges A Leconte, Gillian E Gadbois, Yadira Sepulveda, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Protocols|December 5, 2022
Targeted Protein Degradation: Design Considerations for PROTAC DevelopmentNathan L Tran, Georges A Leconte, Fleur M Ferguson
Bioorganic & Medicinal Chemistry Letters|August 28, 2025
Biochemical investigations into the incorporation of 8-oxo-2'-deoxyguanosine-5'-triphosphate with two A-family polymerasesMichelle L Hamm, Katherine Alexander, Mary W N Burns, et al.
Journal of Medicinal Chemistry|August 5, 2025
A Lipid Prodrug Strategy Enhances Targeted Protein Degrader CNS PharmacokineticsGeorges A Leconte, Gillian E Gadbois, Yadira Sepulveda, et al.
Pageof 1